Normal growth and muscle dysfunction in X-linked hypophosphatemic rickets associated with a novel mutation in the PHEX gene

J Clin Endocrinol Metab. 2008 Apr;93(4):1386-9. doi: 10.1210/jc.2007-1296. Epub 2008 Feb 5.

Abstract

Context: X-linked hypophosphatemic rickets (XLH) is characterized by hypophosphatemia and growth retardation. Early diagnosis and treatment improve growth.

Objective: Our objective was to describe long-term observations of a family with XLH due to a novel mutation of the PHEX gene with unusual clinical features, including normal growth.

Patients: The mother and her two sons were followed in the same institution for nearly 30 yr.

Results: The mother had hypophosphatemia and normal height (Z score, -0.6) without ever receiving any treatment. Her two sons achieved final heights of 183.7 cm (Z score, -0.01) and 182.7 cm (Z score, -0.18), respectively, despite late initiation of treatment with phosphate and low serum phosphate levels. In addition, they had reversible proximal myopathy that took about 7 yr to resolve in one of them. Direct sequencing of the PHEX gene revealed a new splice site mutation in intron 4 of the gene (IVS4+6T-->C) resulting in skipping of exon 4.

Conclusions: Three members of a family with XLH due to a novel mutation of the PHEX gene had a normal growth pattern despite late diagnosis and treatment of the two boys and no treatment at all of their mother. The pathophysiological basis of this phenotype-genotype association warrants further investigation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bone Density
  • Familial Hypophosphatemic Rickets / genetics*
  • Female
  • Genetic Diseases, X-Linked*
  • Growth
  • Humans
  • Male
  • Middle Aged
  • Muscular Diseases / genetics*
  • Mutation*
  • PHEX Phosphate Regulating Neutral Endopeptidase / genetics*

Substances

  • PHEX Phosphate Regulating Neutral Endopeptidase
  • PHEX protein, human